These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34521210)

  • 1. How Physician Workforce Shortages Are Hampering the Response to the Opioid Crisis.
    McNeely J; Schatz D; Olfson M; Appleton N; Williams AR
    Psychiatr Serv; 2022 May; 73(5):547-554. PubMed ID: 34521210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying lessons from task sharing in global mental health to the opioid crisis.
    Magidson JF; Jack HE; Regenauer KS; Myers B
    J Consult Clin Psychol; 2019 Oct; 87(10):962-966. PubMed ID: 31556672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Academic Medicine Can Help Confront the Opioid Crisis.
    Volkow ND; McLellan T; Blanco C
    Acad Med; 2022 Feb; 97(2):171-174. PubMed ID: 34348384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Opioid Epidemic: Challenge to Military Medicine and National Security.
    Dembek ZF; Chekol T; Wu A
    Mil Med; 2020 Jun; 185(5-6):e662-e667. PubMed ID: 32077961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.
    Haffajee RL; Bohnert ASB; Lagisetty PA
    Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S230-S242. PubMed ID: 29779547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing a Telehealth Program in Primary Care for the Treatment of Opioid Use Disorder.
    Coulter KJ; Hintzsche MF
    J Dr Nurs Pract; 2020 Nov; 13(3):207-215. PubMed ID: 33334926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nudging primary care providers to expand the opioid use disorder workforce.
    Domino ME; Sylvia S; Green S
    Health Serv Res; 2022 Apr; 57(2):403-410. PubMed ID: 34648182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences of three states implementing the Medicaid health home model to address opioid use disorder-Case studies in Maryland, Rhode Island, and Vermont.
    Clemans-Cope L; Wishner JB; Allen EH; Lallemand N; Epstein M; Spillman BC
    J Subst Abuse Treat; 2017 Dec; 83():27-35. PubMed ID: 29129193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Now hospital leaders are paying attention": A qualitative study of internal and external factors influencing addiction consult services.
    Priest KC; Englander H; McCarty D
    J Subst Abuse Treat; 2020 Mar; 110():59-65. PubMed ID: 31952629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study.
    Barocas JA; Savinkina A; Adams J; Jawa R; Weinstein ZM; Samet JH; Linas BP
    Lancet Public Health; 2022 Jan; 7(1):e56-e64. PubMed ID: 34861189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
    Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
    JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain and Addiction: The Distribution of Supply and Demand During the Opioid Epidemic.
    Yoo M; Perret D; Dusto N; Lin K; Whyte J
    Am J Phys Med Rehabil; 2022 Jul; 101(7):702-707. PubMed ID: 34686634
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.